Developer docs
API playgroundTry for free, no card

Search company profiles

BridgeView Life Sciences

Full company profile

uuid0009bhw

Namestring
BridgeView Life Sciences
Legal namestring
BridgeView Life Sciences LLC
Company typeenum
Private
Founded yearint
2021
Descriptiontext

BridgeView Life Sciences LLC provides SaaS platforms and consulting services to pharmaceutical, biotechnology, and medical device organizations, operating as a wholly-owned subsidiary of Zensar Technologies (an RPG Group company) since August 2024. The company traces its origin to COEUS Solutions, launched in March 2021 and rebranded as BridgeView Life Sciences in April 2024 following a spinoff from predecessor COEUS Holdings; predecessor entity Afore, LLC was acquired in September 2021 to expand technology capabilities. The product portfolio centers on three core cloud-native SaaS platforms — DataBridge (commercial data warehouse), PatientBridge (specialty patient data aggregation with HIPAA-compliant dashboards), and CommandBridge (program management for large initiatives) — augmented by the 2026 ZenseAI.Veeva suite covering GenAI-powered Field Enablement on Veeva DAM, an AI-driven AMS agent for Veeva Vault support, and a Key Account Management Accelerator integrated with Veeva Vault CRM. Strategic partnerships with Vodori (2026, MLR content review), Veeva (Global Service Partner since 2018), Salesforce (Platinum, including Life Science Cloud), Snowflake, Reltio, Databricks, IQVIA, Aprimo, and others enable integrated solutions across the life sciences technology stack.

Revenue is generated through three streams: subscription/recurring SaaS platforms (DataBridge, PatientBridge, CommandBridge), professional services consulting (Strategy Consulting, Business Transformation, CRM and Business Applications, Information Management and Analytics, Quality Assurance, Technology Training, Managed Services, PMO), and managed services/staff augmentation across US onshore and LATAM/Canada nearshore delivery. Customers span large global pharma, mid-size pharma, biotech (including ultra-rare and oncology), and MedTech organizations; sales are executed via enterprise field sales targeting CXO/VP stakeholders with documented $3M+ annual total contract value deals, supplemented by partner-channel referrals from technology vendors and conference-driven pipeline development. Quantified outcomes cited by the company include 30-60% faster MLR review cycles, 40% acceleration in content approvals (Abiomed case study), up to 30% reduction in operational costs via Agentic AI support, and 30-40% effort savings with automated access management, with compliance maintained across 21 CFR Part 11, EU Annex 11, GxP, HIPAA, and FDA frameworks.

Short descriptiontext

BridgeView Life Sciences provides SaaS platforms and consulting services to pharmaceutical, biotechnology, and medical device firms, specializing in commercial data management, CRM implementation, AI-enabled content review, and program management across the Veeva and Salesforce technology stacks.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersPaoli, United States
HQ citystring
Paoli
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
life sciences consulting, commercial data warehouse, pharmaceutical CRM implementation, MLR content review, biotech SaaS platforms
Industry3 codes
1Data, Analytics & AI Consulting
CodeBPAHAEAFPrimaryYes
2Software/Application Support (SaaS, Enterprise Apps)
CodeBPAAACACPrimaryNo
3Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
CodeHLAGAJACPrimaryNo
NAICS code3 codes
  • Management Consulting Services54161
  • Custom Computer Programming Services541511
  • Computer Systems Design and Related Services54151
SIC code3 codes
  • Services-Management Consulting Services8742
  • Services-Prepackaged Software7372
  • Services-Computer Programming Services7371
Product category
Life Sciences Consulting and SaaS
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1SaaS Products
TypeSubscription Recurring
Description

Cloud-native SaaS platforms including DataBridge, PatientBridge, and CommandBridge for commercial data management, patient data aggregation, and program management. Revenue generated through platform subscriptions and usage.

bridgeviewls.com
2Consulting Services
TypeProfessional Services
Description

Comprehensive range of strategies, solutions, insights, and managed services including Strategy Consulting, Business Transformation, Program Management Office, CRM & Business Applications, Information Management & Analytics, Quality Assurance, Technology Training, and Staff Augmentation. Revenue generated through professional services engagements.

bridgeviewls.com
3Managed Services
TypeManaged Services
Description

Ongoing support services for operation and optimization including world-class system administration, data management, and staff augmentation. Delivered through dedicated managed teams with predictable recurring revenue.

bridgeviewls.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1DataBridge
Description

Commercial data warehouse platform providing flexible, scalable data synthesis, enrichment, and application for commercial stakeholders.

bridgeviewls.com
+2 more records
Core offering1 text field

BridgeView Life Sciences sells cloud-native SaaS platforms (DataBridge, PatientBridge, CommandBridge) and AI-enabled Veeva modules (ZenseAI.Veeva.Field Enablement, ZenseAI.Veeva.AMS, Vault CRM KAM Accelerator) to pharmaceutical, biotech, and medtech organizations for commercial data management, patient journey analytics, program management, and compliant content review. The company complements these products with a full suite of consulting services including strategy, business transformation, CRM implementation, information management, quality assurance, managed services, and staff augmentation.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 30-60% faster MLR review cycles while maintaining compliance
+4 more records
Product overview1 text field

BridgeView Life Sciences offers a portfolio of three core SaaS products (DataBridge, PatientBridge, CommandBridge) supported by ZenseAI.Veeva specialized modules (Field Enablement, AMS, KAM Accelerator) and strategic partnerships. DataBridge serves as the commercial data warehouse platform for data synthesis and analytics; PatientBridge handles specialty patient data aggregation with HIPAA-compliant dashboards; CommandBridge provides program management for large-scale initiatives. ZenseAI.Veeva modules add AI-powered capabilities for Veeva CRM environments, including field enablement with GenAI, AI-driven application support, and key account management. The MLR partnership with Vodori extends capabilities for compliant content review with 30-60% faster cycles. Comprehensive consulting services span strategy, business transformation, CRM, information management, quality assurance, training, managed services, and staff augmentation.

Product and service4 records
1DataBridge
CategoryCommercial Data Warehouse SaaS
Description

Cloud-native commercial data warehouse platform that ingests, stores, governs, and analyzes data from heterogeneous sources including databases, business applications, and industry-standard solutions. Enables accurate ad-hoc analysis, rapid BI reporting, and AI/ML-enabled advanced data science for commercial stakeholders at pharmaceutical and biotech organizations.

2PatientBridge
CategoryPatient Data Analytics SaaS
Description

Specialty data aggregation platform providing near real-time insights beyond traditional channel and prescriber commercial metrics. Validates, tokenizes, masters, and harmonizes data from multiple sources across the product and patient journey, visualizing HIPAA-compliant data in dashboards for trade, market access, and sales teams.

3CommandBridge
CategoryProgram Management SaaS
Description

Program management SaaS platform that strengthens role-specific decision making for large-scale initiatives and operations. Automates subjective topics, bridges information gaps to accelerate planning and launches, mitigates risk, ensures compliance and audit readiness, and creates a single source of truth for program stakeholders.

4ZenseAI.Veeva.Field Enablement
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-14
Description

Strategic partnership announced January 2026 combining Vodori's MLR content review technology with BridgeView's regulatory expertise and implementation support. Joint solution enables 30-60% faster review cycles while maintaining 21 CFR Part 11 and EU Annex 11 compliance. Both companies are Salesforce Life Science Cloud partners. Fixed-price implementation bundle enables go-live in 4-8 weeks.

Strategic tierCoreTypeImplementation/ SI/ Consulting PartnerAnnounced on2018-01-01
Description

Global Service Partner to Veeva Systems since 2018. BridgeView delivers end-to-end Veeva Vault services including configuration, compliance, PromoMats, MedComms, Training, RIM, and CRM implementations. Certified experts help streamline processes and ensure regulatory readiness.

Strategic tierCoreTypeTechnology or Integration
Description

Salesforce Platinum Partner with expertise in Salesforce Health Cloud, Sales Cloud, Service Cloud, and Marketing Cloud implementations. Both BridgeView and Vodori are Salesforce Life Science Cloud partners, enabling integrated solutions.

Strategic tierMajorTypeTechnology or Integration
Description

Snowflake partner providing cloud data platform expertise. BridgeView offers Snowflake Solution Architect roles and Snowflake-based data platform implementations for life sciences customers.

Strategic tierMajorTypeTechnology or Integration
Description

Reltio partner offering AI-powered data unification and Master Data Management (MDM) solutions. Reltio's multidomain MDM platform integrates with BridgeView's data management services.

Strategic tierMajorTypeTechnology or Integration
Description

Partnership with IQVIA for advanced analytics, technology solutions, and clinical research services. IQVIA provides analytics, transformative technology, big data resources, and domain expertise across healthcare.

Strategic tierMajorTypeTechnology or Integration
Description

Databricks partner providing unified Data and AI platform for life sciences organizations. BridgeView leverages Databricks for consolidating data, building AI-driven applications, and ensuring secure governance.

Strategic tierStandardTypeTechnology or Integration
Description

Aprimo partner offering Digital Asset Management, Work Management, and Marketing Budget Management solutions. Integration supports content operations and MLR review workflows.

Strategic tierNotableTypeStrategic or Co-development Partner
Description

IntegriChain acquired BridgeView Data Solutions in 2024, creating best-in-class commercial data solution for pharma. Partnership focuses on data, technology, consulting, and outsourcing connecting commercial, financial, and operational dimensions of drug access.

Strategic tierStandardTypeTechnology or Integration
Description

MedPro partner providing aggregate spend, DSCSA, PDMA, and Stark Law compliance solutions through MedProID platform and expert compliance advisory services.

Strategic tierStandardTypeTechnology or Integration
Description

Smartsheet partner providing enterprise platform for modern work management. BridgeView utilizes Smartsheet for project management and program tracking.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

ImmPACT Bio develops logic-gate-based CAR T platforms addressing key challenges for cell therapies in oncology. Partnership supports biotech innovation in cell therapy space.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

BridgeView Life Sciences was acquired by Zensar Technologies, a leading experience, engineering, and technology solutions company. Zensar provides global scale and digital expertise enabling BridgeView to reach wider audience. BridgeView's transformation expertise enhances Zensar's life sciences offerings.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Premier global life sciences consulting firm with deep commercial, data, and analytics practices serving top pharma and biotech. Competes directly with BridgeView on CRM, data management, and sales force optimization engagements for the same enterprise buyers.

TypeDirect peer
Description

Largest life sciences technology and analytics provider; overlaps with BridgeView in commercial data, technology services, and analytics — and is also a named BridgeView partner, reflecting the dual competitor-and-partner dynamic in this space.

TypeDirect peer
Description

Life sciences-focused data analytics and commercial operations consultancy. Competes head-to-head with BridgeView on sales/marketing analytics, data management, and CRM implementations for pharma and biotech clients.

TypeDirect peer
Description

Life sciences digital services and commercial outsourcing company serving global pharma and biotech. Directly comparable to BridgeView's commercial launch, MLR, and digital content capabilities.

TypeDirect peer
Description

Life sciences commercial consulting and data analytics firm focused on pricing, market access, and customer engagement. Overlaps with BridgeView's PatientBridge and commercial data practices for mid-market pharma.

TypeBroad incumbent
Description

Global IT services practice serving top pharma and medtech accounts. Competes with BridgeView on large CRM, data, and digital transformation engagements as a much larger incumbent with broader capabilities.

TypeBroad incumbent
Description

Global IT services and consulting firm with a sizable life sciences practice providing CRM, data, and digital transformation services. Competes with BridgeView on enterprise pharma IT services and Veeva implementations.

TypeBroad incumbent
Description

Big Four advisory practice with a global life sciences consulting business. Competes with BridgeView on enterprise strategy, transformation, and compliance-related advisory for pharma and medtech clients.

TypeBroad incumbent
Description

Global IT services firm with a dedicated life sciences digital practice serving pharma, biotech, and medtech with CRM, data, and engineering services. Analogous incumbent to BridgeView's niche offering at much larger scale.

TypeBroad incumbent
Description

Global digital engineering and consulting firm with life sciences capabilities across data, cloud, and digital transformation. Competes with BridgeView for large enterprise pharma programs where global delivery scale is required.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration15 records

Each record includes

Title, Type, Description, Source

AI capability13 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BridgeView Life Sciences

Life Sciences Consulting and SaaSbridgeviewls.com

BridgeView Life Sciences provides SaaS platforms and consulting services to pharmaceutical, biotechnology, and medical device firms, specializing in commercial data management, CRM implementation, AI-enabled content review, and program management across the Veeva and Salesforce technology stacks.

What BridgeView Life Sciences does

BridgeView Life Sciences LLC provides SaaS platforms and consulting services to pharmaceutical, biotechnology, and medical device organizations, operating as a wholly-owned subsidiary of Zensar Technologies (an RPG Group company) since August 2024. The company traces its origin to COEUS Solutions, launched in March 2021 and rebranded as BridgeView Life Sciences in April 2024 following a spinoff from predecessor COEUS Holdings; predecessor entity Afore, LLC was acquired in September 2021 to expand technology capabilities. The product portfolio centers on three core cloud-native SaaS platforms — DataBridge (commercial data warehouse), PatientBridge (specialty patient data aggregation with HIPAA-compliant dashboards), and CommandBridge (program management for large initiatives) — augmented by the 2026 ZenseAI.Veeva suite covering GenAI-powered Field Enablement on Veeva DAM, an AI-driven AMS agent for Veeva Vault support, and a Key Account Management Accelerator integrated with Veeva Vault CRM. Strategic partnerships with Vodori (2026, MLR content review), Veeva (Global Service Partner since 2018), Salesforce (Platinum, including Life Science Cloud), Snowflake, Reltio, Databricks, IQVIA, Aprimo, and others enable integrated solutions across the life sciences technology stack.

Revenue is generated through three streams: subscription/recurring SaaS platforms (DataBridge, PatientBridge, CommandBridge), professional services consulting (Strategy Consulting, Business Transformation, CRM and Business Applications, Information Management and Analytics, Quality Assurance, Technology Training, Managed Services, PMO), and managed services/staff augmentation across US onshore and LATAM/Canada nearshore delivery. Customers span large global pharma, mid-size pharma, biotech (including ultra-rare and oncology), and MedTech organizations; sales are executed via enterprise field sales targeting CXO/VP stakeholders with documented $3M+ annual total contract value deals, supplemented by partner-channel referrals from technology vendors and conference-driven pipeline development. Quantified outcomes cited by the company include 30-60% faster MLR review cycles, 40% acceleration in content approvals (Abiomed case study), up to 30% reduction in operational costs via Agentic AI support, and 30-40% effort savings with automated access management, with compliance maintained across 21 CFR Part 11, EU Annex 11, GxP, HIPAA, and FDA frameworks.

BridgeView Life Sciences firmographics

Firmographics
Name
BridgeView Life Sciences
Legal name
BridgeView Life Sciences LLC
Website
https://bridgeviewls.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
51–100 employees
Short description
BridgeView Life Sciences provides SaaS platforms and consulting services to pharmaceutical, biotechnology, and medical device firms, specializing in commercial data management, CRM implementation, AI-enabled content review, and program management across the Veeva and Salesforce technology stacks.
Ownership category
akta.pro rank

BridgeView Life Sciences industry classification

Industry
Product category
Life Sciences Consulting and SaaS
NAICS
Management Consulting Services (54161), Custom Computer Programming Services (541511), Computer Systems Design and Related Services (54151)
SIC
Services-Management Consulting Services (8742), Services-Prepackaged Software (7372), Services-Computer Programming Services (7371)
akta.pro primary industry
Data, Analytics & AI Consulting (BPAHAEAF)
akta.pro secondary industries
Software/Application Support (SaaS, Enterprise Apps) (BPAAACAC), Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)

Keywords

  • Life sciences consulting
  • Commercial data warehouse
  • Pharmaceutical CRM implementation
  • MLR content review
  • Biotech SaaS platforms

Where BridgeView Life Sciences is headquartered

Location

Headquarters

HQ city
Paoli
HQ country
United States
HQ region
North America

Offices1 record

Markets served

BridgeView Life Sciences business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. SaaS Products: Cloud-native SaaS platforms including DataBridge, PatientBridge, and CommandBridge for commercial data management, patient data aggregation, and program management. Revenue generated through platform subscriptions and usage.
  2. Consulting Services: Comprehensive range of strategies, solutions, insights, and managed services including Strategy Consulting, Business Transformation, Program Management Office, CRM & Business Applications, Information Management & Analytics, Quality Assurance, Technology Training, and Staff Augmentation. Revenue generated through professional services engagements.
  3. Managed Services: Ongoing support services for operation and optimization including world-class system administration, data management, and staff augmentation. Delivered through dedicated managed teams with predictable recurring revenue.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

BridgeView Life Sciences product offering

Product offering

Core offering

BridgeView Life Sciences sells cloud-native SaaS platforms (DataBridge, PatientBridge, CommandBridge) and AI-enabled Veeva modules (ZenseAI.Veeva.Field Enablement, ZenseAI.Veeva.AMS, Vault CRM KAM Accelerator) to pharmaceutical, biotech, and medtech organizations for commercial data management, patient journey analytics, program management, and compliant content review. The company complements these products with a full suite of consulting services including strategy, business transformation, CRM implementation, information management, quality assurance, managed services, and staff augmentation.

Product overview

BridgeView Life Sciences offers a portfolio of three core SaaS products (DataBridge, PatientBridge, CommandBridge) supported by ZenseAI.Veeva specialized modules (Field Enablement, AMS, KAM Accelerator) and strategic partnerships. DataBridge serves as the commercial data warehouse platform for data synthesis and analytics; PatientBridge handles specialty patient data aggregation with HIPAA-compliant dashboards; CommandBridge provides program management for large-scale initiatives. ZenseAI.Veeva modules add AI-powered capabilities for Veeva CRM environments, including field enablement with GenAI, AI-driven application support, and key account management. The MLR partnership with Vodori extends capabilities for compliant content review with 30-60% faster cycles. Comprehensive consulting services span strategy, business transformation, CRM, information management, quality assurance, training, managed services, and staff augmentation.

Differentiator

Problem solved

Functional benefit

Brands

  • DataBridge: Commercial data warehouse platform providing flexible, scalable data synthesis, enrichment, and application for commercial stakeholders.
  • PatientBridge
  • CommandBridge

Products and services

  • DataBridge Cloud-native commercial data warehouse platform that ingests, stores, governs, and analyzes data from heterogeneous sources including databases, business applications, and industry-standard solutions. Enables accurate ad-hoc analysis, rapid BI reporting, and AI/ML-enabled advanced data science for commercial stakeholders at pharmaceutical and biotech organizations.
  • PatientBridge Specialty data aggregation platform providing near real-time insights beyond traditional channel and prescriber commercial metrics. Validates, tokenizes, masters, and harmonizes data from multiple sources across the product and patient journey, visualizing HIPAA-compliant data in dashboards for trade, market access, and sales teams.
  • CommandBridge Program management SaaS platform that strengthens role-specific decision making for large-scale initiatives and operations. Automates subjective topics, bridges information gaps to accelerate planning and launches, mitigates risk, ensures compliance and audit readiness, and creates a single source of truth for program stakeholders.
  • ZenseAI.Veeva.Field Enablement

Quantifiable outcome

  • 30-60% faster MLR review cycles while maintaining compliance
  • +4 more outcomes

Companies that use BridgeView Life Sciences

Customer profile

Named customers11 records

Segments4 records

Ideal customer profiles3 records

BridgeView Life Sciences technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration15 records

AI capability13 records

Feature8 records

BridgeView Life Sciences partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core, major, standard, notable and minor.

  • VodoricoreStrategic or Co-development Partner · 14 January 2026Strategic partnership announced January 2026 combining Vodori's MLR content review technology with BridgeView's regulatory expertise and implementation support. Joint solution enables 30-60% faster review cycles while maintaining 21 CFR Part 11 and EU Annex 11 compliance. Both companies are Salesforce Life Science Cloud partners. Fixed-price implementation bundle enables go-live in 4-8 weeks.
  • Veeva SystemscoreImplementation/ SI/ Consulting Partner · 1 January 2018Global Service Partner to Veeva Systems since 2018. BridgeView delivers end-to-end Veeva Vault services including configuration, compliance, PromoMats, MedComms, Training, RIM, and CRM implementations. Certified experts help streamline processes and ensure regulatory readiness.
  • SalesforcecoreTechnology or IntegrationSalesforce Platinum Partner with expertise in Salesforce Health Cloud, Sales Cloud, Service Cloud, and Marketing Cloud implementations. Both BridgeView and Vodori are Salesforce Life Science Cloud partners, enabling integrated solutions.
  • SnowflakemajorTechnology or IntegrationSnowflake partner providing cloud data platform expertise. BridgeView offers Snowflake Solution Architect roles and Snowflake-based data platform implementations for life sciences customers.
  • ReltiomajorTechnology or IntegrationReltio partner offering AI-powered data unification and Master Data Management (MDM) solutions. Reltio's multidomain MDM platform integrates with BridgeView's data management services.
  • IQVIAmajorTechnology or IntegrationPartnership with IQVIA for advanced analytics, technology solutions, and clinical research services. IQVIA provides analytics, transformative technology, big data resources, and domain expertise across healthcare.
  • DatabricksmajorTechnology or IntegrationDatabricks partner providing unified Data and AI platform for life sciences organizations. BridgeView leverages Databricks for consolidating data, building AI-driven applications, and ensuring secure governance.
  • AprimostandardTechnology or IntegrationAprimo partner offering Digital Asset Management, Work Management, and Marketing Budget Management solutions. Integration supports content operations and MLR review workflows.
  • IntegriChainnotableStrategic or Co-development PartnerIntegriChain acquired BridgeView Data Solutions in 2024, creating best-in-class commercial data solution for pharma. Partnership focuses on data, technology, consulting, and outsourcing connecting commercial, financial, and operational dimensions of drug access.
  • MedPro SystemsstandardTechnology or IntegrationMedPro partner providing aggregate spend, DSCSA, PDMA, and Stark Law compliance solutions through MedProID platform and expert compliance advisory services.
  • SmartsheetstandardTechnology or IntegrationSmartsheet partner providing enterprise platform for modern work management. BridgeView utilizes Smartsheet for project management and program tracking.
  • ImmPACT BiominorStrategic or Co-development PartnerImmPACT Bio develops logic-gate-based CAR T platforms addressing key challenges for cell therapies in oncology. Partnership supports biotech innovation in cell therapy space.
  • Zensar TechnologiescoreStrategic or Co-development PartnerBridgeView Life Sciences was acquired by Zensar Technologies, a leading experience, engineering, and technology solutions company. Zensar provides global scale and digital expertise enabling BridgeView to reach wider audience. BridgeView's transformation expertise enhances Zensar's life sciences offerings.

Scale indicators4 records

Recent moves8 records

Expansion highlights6 records

BridgeView Life Sciences competitors and assessment

Company assessment

Direct peers

  • ZS Associates: Premier global life sciences consulting firm with deep commercial, data, and analytics practices serving top pharma and biotech. Competes directly with BridgeView on CRM, data management, and sales force optimization engagements for the same enterprise buyers.
  • IQVIA: Largest life sciences technology and analytics provider; overlaps with BridgeView in commercial data, technology services, and analytics — and is also a named BridgeView partner, reflecting the dual competitor-and-partner dynamic in this space.
  • Axtria: Life sciences-focused data analytics and commercial operations consultancy. Competes head-to-head with BridgeView on sales/marketing analytics, data management, and CRM implementations for pharma and biotech clients.
  • Indegene: Life sciences digital services and commercial outsourcing company serving global pharma and biotech. Directly comparable to BridgeView's commercial launch, MLR, and digital content capabilities.
  • Navience Life Sciences: Life sciences commercial consulting and data analytics firm focused on pricing, market access, and customer engagement. Overlaps with BridgeView's PatientBridge and commercial data practices for mid-market pharma.

Broad incumbents

  • Accenture Life Sciences: Global IT services practice serving top pharma and medtech accounts. Competes with BridgeView on large CRM, data, and digital transformation engagements as a much larger incumbent with broader capabilities.
  • Cognizant Life Sciences: Global IT services and consulting firm with a sizable life sciences practice providing CRM, data, and digital transformation services. Competes with BridgeView on enterprise pharma IT services and Veeva implementations.
  • Deloitte Life Sciences Consulting: Big Four advisory practice with a global life sciences consulting business. Competes with BridgeView on enterprise strategy, transformation, and compliance-related advisory for pharma and medtech clients.
  • Wipro Life Sciences: Global IT services firm with a dedicated life sciences digital practice serving pharma, biotech, and medtech with CRM, data, and engineering services. Analogous incumbent to BridgeView's niche offering at much larger scale.
  • Capgemini Engineering: Global digital engineering and consulting firm with life sciences capabilities across data, cloud, and digital transformation. Competes with BridgeView for large enterprise pharma programs where global delivery scale is required.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

BridgeView Life Sciences social profiles

Digital presence

BridgeView Life Sciences compliance and trust

Trust signal

Compliance5 records

BridgeView Life Sciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BridgeView Life Sciences leadership team

Management profile

Number of profiles

Profiles4 records

BridgeView Life Sciences funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BridgeView Life Sciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BridgeView Life Sciences

What does BridgeView Life Sciences do?

BridgeView Life Sciences sells cloud-native SaaS platforms (DataBridge, PatientBridge, CommandBridge) and AI-enabled Veeva modules (ZenseAI.Veeva.Field Enablement, ZenseAI.Veeva.AMS, Vault CRM KAM Accelerator) to pharmaceutical, biotech, and medtech organizations for commercial data management, patient journey analytics, program management, and compliant content review. The company complements these products with a full suite of consulting services including strategy, business transformation, CRM implementation, information management, quality assurance, managed services, and staff augmentation.

Is BridgeView Life Sciences a public or private company?

BridgeView Life Sciences is a private company. It is classified as corporate owned and is currently operating.

When was BridgeView Life Sciences founded?

BridgeView Life Sciences was founded in 2021. It employs 51 to 100 people.

Where is BridgeView Life Sciences based?

BridgeView Life Sciences is headquartered in Paoli, United States, in the North America region.

How does BridgeView Life Sciences make money?

Three revenue lines are on record. SaaS Products are the primary driver. The others are consulting Services and managed Services.

Who are BridgeView Life Sciences's main competitors?

Direct peers on record are ZS Associates, IQVIA, Axtria, Indegene and Navience Life Sciences. Broad incumbents are Accenture Life Sciences, Cognizant Life Sciences, Deloitte Life Sciences Consulting, Wipro Life Sciences and Capgemini Engineering.

Does BridgeView Life Sciences have an API?

No public API is recorded for BridgeView Life Sciences.

What industry is BridgeView Life Sciences in?

BridgeView Life Sciences's product category is Life Sciences Consulting and SaaS. Its primary akta.pro industry code is BPAHAEAF, Data, Analytics & AI Consulting, with a secondary code of BPAAACAC, Software/Application Support (SaaS, Enterprise Apps). Its NAICS code is 54161 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ScanXZensar Technologies completes merger of two US subsidiariesZensar Technologies completed the merger of its US subsidiaries M3BI LLC and Bridgeview Life Sciences LLC into Zensar Technologies Inc., with the transaction becoming effective on September 1, 2026. The consolidation follows board approval in July and the completion of primary regulatory filings, though some post-merger administrative processes remain ongoing. This procedural restructuring aims to consolidate entities under the company's main US subsidiary without reported immediate financial or operational performance changes.ScanXZensar Technologies approves merger of US subsidiariesZensar Technologies Limited approved the merger of its US subsidiaries Bridgeview Life Sciences LLC and M3BI LLC into Zensar Technologies Inc. on July 29, 2026. The restructuring aims to improve operational efficiency and synergies while leaving the listed company's shareholding pattern unchanged. This consolidation streamlines the company's US operations structure to support larger integrated digital transformation contracts in the North American market.Tallahassee DemocratVodori and BridgeView announce strategic partnership to transform content review across the life science industryVodori and BridgeView, a Zensar company, announced a strategic partnership to integrate Vodori's MLR technology with BridgeView's regulatory expertise for life sciences content review. This collaboration aims to help pharmaceutical and biotech companies reduce review cycles by 30-60% through compliant, scalable solutions.New Bedford Standard-TimesVodori and BridgeView announce strategic partnership to transform content review across the life science industryVodori, a provider of cloud-based compliant content management solutions for life sciences, and BridgeView Life Sciences, a Zensar company and full-service consulting partner, announced a new strategic partnership focused on helping life sciences companies modernize their promotional and medical content review processes. The combined solution integrates Vodori's Medical-Legal-Regulatory Content Review technology with BridgeView's regulatory expertise and implementation support, enabling 30-60% faster review cycles while maintaining 21 CFR Part 11 and EU Annex 11 compliance. Both companies are Salesforce Life Science Cloud partners, and the solution is designed to serve teams across pharma, biotech, and medtech sectors.BlinkxZensar Tech Acquires US-Based BridgeView to Expand Healthcare Solutions - NewsZensar Technologies announced the acquisition of 100% membership interest in US-based BridgeView Life Sciences for an upfront payment of USD 14.0 million, with potential additional payments of up to USD 11.0 million. The transaction is expected to close within two to three weeks and aims to strengthen Zensar's Healthcare and Life Sciences vertical by expanding its service offerings to pharmaceutical and biotechnology clients.Business StandardZensar acquires BridgeView to expand into biopharma, life sciences industryZensar Technologies has agreed to acquire BridgeView Lifesciences for a total deal value of $25 million to expand its healthcare and life sciences capabilities. The transaction involves an upfront payment of $14 million and up to $11 million in contingent payments based on performance thresholds, with completion expected within 2-3 weeks. This move aims to deepen services for existing clients and enter new markets for innovators and emerging pharma players.The Times of IndiaZensar Technologies to buy US firm BridgeView Life Sciences - The Economic TimesZensar Technologies has agreed to acquire 100% of BridgeView Life Sciences for a total consideration of $25 million, consisting of an upfront payment and contingent future payments. The acquisition is intended to strengthen Zensar's Healthcare and Life Sciences vertical by adding expertise in pharma commercial services and biopharma cloud CRM. This strategic move aims to expand Zensar's solution suite for pharmaceutical, biotechnology, and medical device companies.PR NewswireIntegriChain Acquires BridgeView Data Solutions, Creating the Pharmaceutical Industry's Best-in-Class Commercial Data SolutionIntegriChain announced the acquisition of BridgeView Data Solutions, integrating its commercial data warehouse and AI-enabled exploration capabilities into IntegriChain's ICyte platform. This transaction represents IntegriChain's sixth expansion and follows its strategic partnership with Nordic Capital, aiming to create a comprehensive data solution for pharmaceutical manufacturers.PR NewswireCOEUS Solutions Rebrands as BridgeView Life Sciences After Successful SpinoffCOEUS Solutions announced its rebranding to BridgeView Life Sciences following a recent spinoff from its former parent company, marking a strategic milestone for the company. The newly rebranded firm offers SaaS platforms including DataBridge, PatientBridge, and CommandBridge, along with strategy consulting and managed services for life sciences organizations. BridgeView Life Sciences stated it will leverage the spinoff to pursue global expansion, introduce new solutions, and deepen partnerships across the life sciences industry.